These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

88 related articles for article (PubMed ID: 10635480)

  • 1. [Acute coronary syndrome, stent and cardiac insufficiency. Advances in thrombosis prevention].
    Internist (Berl); 1999 Dec; 40(12 Suppl Fortschrit):1-4. PubMed ID: 10635480
    [No Abstract]   [Full Text] [Related]  

  • 2. Predictive values of post-treatment adenosine diphosphate-induced aggregation and vasodilator-stimulated phosphoprotein index for stent thrombosis after acute coronary syndrome in clopidogrel-treated patients.
    Cuisset T; Frere C; Quilici J; Gaborit B; Castelli C; Poyet R; Bali L; Morange PE; Alessi MC; Bonnet JL
    Am J Cardiol; 2009 Oct; 104(8):1078-82. PubMed ID: 19801028
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clopidogrel resistance--the cardiologist's perspective.
    Fefer P; Hod H; Matetzky S
    Platelets; 2007 May; 18(3):175-81. PubMed ID: 17497429
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Increased long term rates of stent thrombosis and mortality in patients given clopidogrel as compared to ticlopidine following coronary stent implantation.
    Wolak A; Amit G; Cafri C; Gilutz H; Ilia R; Zahger D
    Int J Cardiol; 2005 Sep; 103(3):293-7. PubMed ID: 16098392
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Preventing thrombosis: update of first-line therapy in the management of non-ST segment elevation acute coronary syndromes.
    Fitchett D; Goodman SG; Gupta M; Langer A
    Can J Cardiol; 2002 Nov; 18(11):1179-90. PubMed ID: 12464982
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Treatment of ischemic heart disease with the platelet aggregation inhibitor clopidogrel].
    Helø OH; Madsen JK; Kastrup J
    Ugeskr Laeger; 2004 Apr; 166(18):1659-62. PubMed ID: 15174400
    [No Abstract]   [Full Text] [Related]  

  • 7. Clinical, procedural, and pharmacologic correlates of acute and subacute stent thrombosis: results of a multicenter case-control study with 145 thrombosis events.
    Rinaldi MJ; Kirtane AJ; Piana RN; Caputo RP; Gordon PC; Lopez JJ; Dauerman HL; Ryan TJ; Kiernan FJ; Cutlip DE; Ho KK; Gibson CM; Murphy SA; Cohen DJ
    Am Heart J; 2008 Apr; 155(4):654-60. PubMed ID: 18371472
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Acute coronary syndrome: are intervention and IIb/IIIa platelet inhibitors epiphenomena?
    Jackson G
    Int J Clin Pract; 2001; 55(6):351-2. PubMed ID: 11501219
    [No Abstract]   [Full Text] [Related]  

  • 9. Platelet aggregation inhibitors in prevention and treatment of coronary thrombosis.
    Gomes ME; Verheugt FW
    Neth J Med; 2003 Jun; 61(6):185-92. PubMed ID: 12948162
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Aspirin and clopidogrel in acute coronary syndromes: therapeutic insights from the CURE study.
    Jneid H; Bhatt DL; Corti R; Badimon JJ; Fuster V; Francis GS
    Arch Intern Med; 2003 May; 163(10):1145-53. PubMed ID: 12767950
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Adjunctive therapies in the cath lab. Subacute stent thrombosis developing twelve days after discontinuation of ticlopidine treatment.
    Timurkaynak T; Goksen I; Cengel A; Dortlemez O
    J Invasive Cardiol; 2001 Sep; 13(9):640-3. PubMed ID: 11533502
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Two platelet inhibitors after acute coronary syndrome. Many colleagues are not aware of this].
    MMW Fortschr Med; 2002 Mar; 144(13):50. PubMed ID: 12008695
    [No Abstract]   [Full Text] [Related]  

  • 13. [Antiplatelet agents--problem for cardiac surgeon].
    Bochenek A; Wilczyński M
    Kardiol Pol; 2006 Nov; 64(11):1329-31. PubMed ID: 17165174
    [No Abstract]   [Full Text] [Related]  

  • 14. Antiplatelet agents in acute coronary syndromes.
    Eikelboom JW; Anand S
    Semin Vasc Med; 2003 Nov; 3(4):403-14. PubMed ID: 15199447
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Late stent thrombosis in brachytherapy: the role of long-term antiplatelet therapy.
    Teirstein P; Reilly JP
    J Invasive Cardiol; 2002 Mar; 14(3):109-14. PubMed ID: 11870263
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Validation of predictors of intraprocedural stent thrombosis in the drug-eluting stent era.
    Biondi-Zoccai GG; Sangiorgi GM; Chieffo A; Vittori G; Falchetti E; Margheri M; Barbagallo R; Tamburino C; Remigi E; Briguori C; Iakovou I; Agostoni P; Tsagalou E; Melzi G; Michev I; Airoldi F; Montorfano M; Carlino M; Colombo A;
    Am J Cardiol; 2005 Jun; 95(12):1466-8. PubMed ID: 15950573
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inhibition by combined therapy with ticlopidine and aspirin of enhanced platelet aggregation during physical exercise in patients with coronary artery disease.
    Kitai T; Nishikawa M; Tanigawa T; Okinaka T; Wada H; Shiku H; Ikeda Y; Ito M; Isaka N; Nakano T
    Am Heart J; 2001 Aug; 142(2):E1. PubMed ID: 11479480
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical implications of CURE and PCI-CURE in patients with the acute coronary syndrome without persistent ST-elevation.
    Otterstad JE; Fox KA
    Scand Cardiovasc J; 2002 Sep; 36(5):261-71. PubMed ID: 12470391
    [No Abstract]   [Full Text] [Related]  

  • 19. [Place of ticlopidine in antiplatelet treatment].
    Wlazłowski R; Goch A; Goch JH
    Pol Merkur Lekarski; 2005 Aug; 19(110):131-5. PubMed ID: 16245416
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evolving role of clopidogrel in acute coronary syndromes.
    Salam AM; Al Suwaidi J
    Expert Rev Cardiovasc Ther; 2005 Nov; 3(6):977-80. PubMed ID: 16292986
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.